Explore advanced Pancreatic Cancer Treatment and Care, including the Whipple procedure, specialized chemotherapy, and rehabilitation programs at LIV Hospital.
Send us all your questions or requests, and our expert team will assist you.
Effective management of pancreatic cancer requires a coordinated effort among surgeons, medical oncologists, radiation oncologists, gastroenterologists, and supportive care specialists. This is formalized through the Multidisciplinary Tumor Board, where experts review each case to define the optimal treatment sequence. For patients with resectable disease, surgery represents the only potential for a cure. However, pancreatic surgery is among the most complex in abdominal medicine and is best performed in high-volume centers with specialized expertise.
The most common procedure for tumors located in the pancreatic head is the Pancreaticoduodenectomy, famously known as the Whipple procedure. This intricate operation involves removing the head of the pancreas, the duodenum (the first part of the small intestine), the gallbladder, a portion of the bile duct, and sometimes a portion of the stomach. Reconstruction is critical, requiring the surgeon to reconnect the remaining pancreas, bile duct, and stomach to the small intestine to restore digestive continuity.
For tumors located in the body or tail of the pancreas, a Distal Pancreatectomy is performed. This procedure usually involves the removal of the spleen (splenectomy) as well, because the blood vessels supplying the spleen run closely along the pancreas tail. In rare instances where the tumor involves the entire gland, a Total Pancreatectomy may be necessary. Minimally invasive techniques, including laparoscopic and robotic-assisted surgery, are increasingly utilized for these procedures, offering patients smaller incisions, less pain, and faster recovery times while maintaining oncological safety standards.
Chemotherapy is a systemic treatment that uses powerful drugs to kill cancer cells throughout the body. In pancreatic cancer, chemotherapy plays several roles: it can be given before surgery (neoadjuvant) to shrink tumors, after surgery (adjuvant) to kill any remaining microscopic cells, or as the primary treatment for advanced disease to control growth and extend survival. The biology of pancreatic cancer, with its dense stroma, has historically made it resistant to many drugs, but modern combination regimens have significantly improved outcomes.
The standard of care often involves multi-drug regimens. FOLFIRINOX is a rigorous combination of four different agents (fluorouracil, leucovorin, irinotecan, and oxaliplatin). It is highly effective but can have significant side effects, so patients must have a good performance status. Another everyday regimen is the combination of Gemcitabine and Nab-paclitaxel (albumin-bound paclitaxel). The albumin coating allows the drug to penetrate the tumor stroma more effectively.
For elderly patients or those with other health conditions who cannot tolerate aggressive combinations, single-agent Gemcitabine or other modified regimens may be used. The goal is always to balance maximal tumor control with the preservation of quality of life. During chemotherapy, patients are monitored closely with blood tests and imaging to assess the tumor’s response and manage any toxicities such as neuropathy, fatigue, or immune suppression.
Radiation therapy uses high-energy beams to destroy cancer cells. In pancreatic cancer, it is traditionally used for locally advanced disease where the tumor cannot be removed surgically but has not spread distantly. It serves to control local growth and alleviate pain caused by nerve infiltration. Modern advancements have transformed radiation from a purely palliative tool to a potential partner in curative intent, particularly for borderline resectable cases.
Stereotactic Body Radiation Therapy (SBRT) is a sophisticated technique that delivers very high doses of radiation to the tumor in a few sessions (usually five or fewer) with extreme precision. This minimizes damage to the surrounding stomach and bowel. Another advancement is the MR-Linac, which combines an MRI scanner with a linear accelerator. This allows doctors to see the tumor and surrounding soft tissues in real time as radiation is delivered, adjusting the beam to account for breathing motion.
For patients who are not candidates for surgical removal due to vascular involvement, local ablative therapies such as Irreversible Electroporation (IRE), commercially known as NanoKnife, may be an option. IRE uses high-voltage electrical pulses to create permanent nanopores in tumor cell membranes, causing cell death without relying on thermal energy. This makes it safer to use near critical blood vessels compared to heat-based ablation methods.
The era of “one size fits all” is fading. Precision medicine involves analyzing a tumor’s genetic makeup to identify specific mutations that can be targeted with drugs. While pancreatic cancer has fewer targetable mutations compared to lung or breast cancer, identifying them is crucial. For example, patients with BRCA mutations may respond well to PARP inhibitors, a class of drugs that prevent cancer cells from repairing their damaged DNA.
Immunotherapy, which boosts the body’s immune system to fight cancer, has had limited success in general pancreatic cancer but is highly effective for a small subset of patients. Specifically, tumors that test positive for Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficiency (dMMR) respond robustly to immune checkpoint inhibitors. These drugs remove the “brakes” on the immune system, allowing T cells to recognize and attack the cancer.
Furthermore, tumors harboring NTRK gene fusions can be treated with specific TRK inhibitors. The identification of these molecular subtypes emphasizes the importance of Next-Generation Sequencing (NGS) for every patient with advanced disease. Clinical trials continue to explore vaccines, metabolic inhibitors, and stromal-modulating agents, representing the frontier of hope for future treatments.
Send us all your questions or requests, and our expert team will assist you.
Recovery from a Whipple procedure is significant. Patients typically stay in the hospital for one to two weeks. Upon discharge, it can take several months to return to normal energy levels. The digestive system also takes time to adapt to the reconstruction, and patients may initially experience changes in appetite and bowel habits.
Chemotherapy is given before surgery (neoadjuvant) when the tumor is borderline resectable or locally advanced to shrink it away from blood vessels. It is also increasingly used in clearly resectable cases to treat potential micrometastases early and to test the tumor’s biology. If the cancer grows during chemo, surgery might not be beneficial.
The NanoKnife, or Irreversible Electroporation, destroys cancer cells using electrical pulses rather than heat or cold. This is advantageous because it preserves the structural integrity of the collagen and elastin networks in blood vessels and ducts, allowing surgeons to ablate tumors that are wrapped around vital vessels without causing catastrophic bleeding.
No, external beam radiation therapy, which is the type used for pancreatic cancer, does not make a patient radioactive. The radiation passes through the body to treat the tumor, but no radiation remains in the body after the treatment session is finished. Patients can safely be around pregnant women and children.
FOLFIRINOX is an intense regimen. Tolerance is determined by “Performance Status,” a clinical score evaluating a patient’s daily living abilities. Younger age, good physical fitness, lack of other significant comorbidities (like heart disease), and good liver function are key factors in deciding if a patient can handle this aggressive therapy.
Almost 90% of cancer-related deaths result from metastatic disease, which happens when cancer spreads from its original site to other parts of the body. Understanding
Nearly 1 in 5 cancer patients see their cancer come back, often because the cancer has spread without being caught early. This makes it crucial
Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.
Your Comparison List (you must select at least 2 packages)